FOR JOURNALISTS AND MEDIA REPRESENTATIVES ONLY

 

Astellas Data Presentations

At the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition, which takes place between 11-14 December 2021, Astellas will be sharing data from a total of eleven abstracts focused on acute myeloid leukaemia (AML).

Further information on the Astellas-sponsored abstracts at ASH can be found via the press release.

Press Release

Astellas to Present Research on FLT3 Mutation-Positive Acute Myeloid Leukemia – from Diagnosis to Relapse – at 2021 American Society of Hematology Annual Meeting

  • Four AML oral presentations are among highest number of Astellas-sponsored ASH abstracts to date
  • Phase 3 LACEWING, COMMODORE trials will be presented 
  • Oral presentation explores potential sickle cell disease treatment pathway

Click here to view the press release

 

Press Office

Do you have a media enquiry relating to Astellas at ASH 2021? Contact the EST-C press office via email on [email protected].

 

Date of preparation: December 2021
Date of expiry: December 2023
Document number: ONC_2021_0324_UK